World's Best Scientists 2026 revealed!
Daniel F. Sahm

Daniel F. Sahm

D-Index & Metrics

Microbiology

D-Index
92
Citations
26709
World Ranking
632
National Ranking
293

Overview

Daniel F. Sahm is affiliated with IHMA in the United States. Their research primarily falls within the fields of Biochemistry, Genetics and Molecular Biology, Medicine, and Immunology and Microbiology. The scholar's work extends across various subfields, including Molecular Medicine, Applied Microbiology and Biotechnology, Pharmacology, Epidemiology, and Clinical Biochemistry.

The scientist's research focuses mainly on several key topics: antibiotic resistance in bacteria, antibiotic use and resistance, antibiotics pharmacokinetics and efficacy, pneumonia and respiratory infections, bacterial identification and susceptibility testing, urinary tract infections management, and infections and bacterial resistance.

Daniel F. Sahm has several frequent collaborators, demonstrating ongoing research partnerships with Katherine Young, Mary Motyl, Meredith Hackel, Sibylle Lob, and Mark G. Wise. These co-authors have contributed significantly to the body of work produced.

Their publications appear regularly in a variety of scientific journals, with a notable volume in Open Forum Infectious Diseases, Journal of Global Antimicrobial Resistance, Antimicrobial Agents and Chemotherapy, JAC-Antimicrobial Resistance, and International Journal of Antimicrobial Agents.

Some recent papers authored or co-authored by Daniel F. Sahm include:

  • Trends in Antibiotic Resistance Among Ocular Microorganisms in the United States From 2009 to 2018 (2020), published in JAMA Ophthalmology
  • Reduced susceptibility mechanism to cefiderocol, a siderophore cephalosporin, among clinical isolates from a global surveillance programme (SIDERO-WT-2014) (2020), published in Journal of Global Antimicrobial Resistance
  • Epidemiology of Carbapenem Resistance Determinants Identified in Meropenem-Nonsusceptible Enterobacterales Collected as Part of a Global Surveillance Program, 2012 to 2017 (2021), published in Antimicrobial Agents and Chemotherapy
  • In Vitro Activity of Imipenem/Relebactam and Ceftolozane/Tazobactam Against Clinical Isolates of Gram-negative Bacilli With Difficult-to-Treat Resistance and Multidrug-resistant Phenotypes-Study for Monitoring Antimicrobial Resistance Trends, United States 2015-2017 (2020), published in Clinical Infectious Diseases
  • In Vitro Activity of Cefepime-Taniborbactam and Comparators against Clinical Isolates of Gram-Negative Bacilli from 2018 to 2020: Results from the Global Evaluation of Antimicrobial Resistance via Surveillance (GEARS) Program (2022), published in Antimicrobial Agents and Chemotherapy

Best Publications

  • Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future.

    Mark M. Huycke;Daniel F. Sahm;Michael S. Gilmore

  • Prevalence in the United States of aac(6′)-Ib-cr Encoding a Ciprofloxacin-Modifying Enzyme

    Chi Hye Park;Ari Robicsek;George A. Jacoby;Daniel Sahm

  • qnr Prevalence in Ceftazidime-Resistant Enterobacteriaceae Isolates from the United States

    A. Robicsek;J. Strahilevitz;D. F. Sahm;G. A. Jacoby

  • Relationships between Enterococcal Virulence and Antimicrobial Resistance

    L. M. Mundy;D. F. Sahm;M. Gilmore

  • Trends in Antimicrobial Resistance among Urinary Tract Infection Isolates of Escherichia coli from Female Outpatients in the United States

    James A. Karlowsky;Laurie J. Kelly;Clyde Thornsberry;Mark E. Jones

  • Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States

    David Styers;Daniel J Sheehan;Patricia Hogan;Daniel F Sahm

  • Surveillance for Antimicrobial Susceptibility among Clinical Isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from Hospitalized Patients in the United States, 1998 to 2001

    James A. Karlowsky;Deborah C. Draghi;Mark E. Jones;Clyde Thornsberry

  • Antimicrobial Resistance Among Uropathogens that Cause Community-Acquired Urinary Tract Infections in Women: A Nationwide Analysis

    Kalpana Gupta;Daniel F. Sahm;David Mayfield;Walter E. Stamm

  • Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997-1998.

    Clyde Thornsberry;Mark E. Jones;Mary L. Hickey;Yolanda Mauriz

  • Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000.

    Daniel F. Sahm;Clyde Thornsberry;David C. Mayfield;Mark E. Jones

  • Emerging resistance among bacterial pathogens in the intensive care unit – a European and North American Surveillance study (2000–2002)

    Mark E Jones;Deborah C Draghi;Clyde Thornsberry;James A Karlowsky

  • Emerging plasmid-mediated quinolone resistance associated with the qnr gene in Klebsiella pneumoniae clinical isolates in the United States.

    Minggui Wang;Daniel F. Sahm;George A. Jacoby;David C. Hooper

  • VanE, a New Type of Acquired Glycopeptide Resistance in Enterococcus faecalis BM4405

    Marguerite Fines;Bruno Perichon;Peter Reynolds;Daniel F. Sahm

  • Ocular TRUST: nationwide antimicrobial susceptibility patterns in ocular isolates.

    Penny A. Asbell;Kathryn A. Colby;Sophie Deng;Peter McDonnell

  • Regional Trends in Antimicrobial Resistance among Clinical Isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: Results from the TRUST Surveillance Program, 1999–2000

    Clyde Thornsberry;Daniel F. Sahm;Laurie J. Kelly;Ian A. Critchley

  • Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: a guide to appropriate antimicrobial therapy.

    Mark E. Jones;James A. Karlowsky;Deborah C. Draghi;Clyde Thornsberry

  • Antimicrobial resistance in key bloodstream bacterial isolates: electronic surveillance with the Surveillance Network Database--USA.

    Daniel F. Sahm;Mark K. Marsilio;Geriann Piazza

  • Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae.

    J P Quinn;D Miyashiro;D Sahm;R Flamm

  • Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002

    James A Karlowsky;Mark E Jones;Deborah C Draghi;Clyde Thornsberry

  • In Vitro Activity of the Siderophore Cephalosporin, Cefiderocol, against Carbapenem-Nonsusceptible and Multidrug-Resistant Isolates of Gram-Negative Bacilli Collected Worldwide in 2014 to 2016.

    Meredith A. Hackel;Masakatsu Tsuji;Yoshinori Yamano;Roger Echols

  • Trends in Antimicrobial Resistance among Urinary Tract Infection Isolates of Escherichia coli from Female Outpatients in the

    James A. Karlowsky;Laurie J. Kelly;Clyde Thornsberry;Mark E. Jones

Frequent Co-Authors

Mark E. Jones
Mark E. Jones Basilea Pharmaceutica (Switzerland)
Clyde Thornsberry
Clyde Thornsberry Centers for Disease Control and Prevention
James A. Karlowsky
James A. Karlowsky University of Manitoba
Ian A. Critchley
Ian A. Critchley Spero Therapeutics (United States)
Mary Motyl
Mary Motyl MSD (United States)
Karen Bush
Karen Bush Indiana University
Robert K. Flamm
Robert K. Flamm JMI Laboratories
David C. Hooper
David C. Hooper Massachusetts General Hospital
George A. Jacoby
George A. Jacoby Tufts University
Helio S. Sader
Helio S. Sader JMI Laboratories

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a degree in Microbiology opens doors to various related fields, including healthcare and information management. For those interested in patient care from a broader perspective, becoming a functional medicine nurse practitioner is a promising path that combines microbiological knowledge with holistic health approaches.

Beyond clinical roles, the healthcare industry increasingly relies on accurate data management. Pursuing a certified professional coder (CPC) credential offers a specialized skill set in medical coding, essential for patient record accuracy and billing processes.

Another growing area is health information management. Understanding how to manage medical data effectively is crucial, with roles such as those covered under health information management salary entry-level highlighting strong demand and competitive compensation for new graduates.

For those wanting to advance in this field, selecting one of the best online health information management degree CAHIIM accredited programs ensures quality education that meets industry standards and enhances career opportunities.

Best Scientists Citing Daniel F. Sahm

Trending Scientists

Recently Published Articles